Platelet dysfunction associated with the novel Trp29Cys thromboxane A₂ receptor variant

Area of Science:

• Cardiovascular Biology
• Molecular Genetics
• Pharmacology

Background:

• Genetic variations in the thromboxane A2 receptor (TP receptor) are crucial for understanding platelet and vascular functions.
• Such variations are infrequently observed in general populations, making detailed studies rare.

Observation:

• An index case (P1) presented with diminished platelet aggregation and secretion in response to TP receptor activators.
• P1 carried a heterozygous TP receptor Trp29Cys (W29C) substitution.

Findings:

• The W29C TP receptor variant exhibited reduced affinity for the antagonist [(3)H]SQ29548 and impaired agonist (U46619) potency in HEK293 cells.
• Cellular analysis revealed intracellular retention and decreased surface expression of the W29C TP receptor.
• Platelet studies mirrored cellular findings, showing reduced antagonist binding and affinity.

Implications:

• This study elucidates the functional consequences of the rare TP receptor W29C substitution.
• The findings contribute to the understanding of TP receptor deficiency disorders.
• Reduced TP receptor surface expression and disrupted ligand binding underlie the observed functional deficits.